unknown by Ralf Kuhlen et al.
Fluctuations of inspired concentrations of nitric oxide and
nitrogen dioxide during mechanical ventilation
Ralf Kuhlen*, Thilo Busch†, Martin Max*, Matthias Reyle-Hahn*, Konrad J Falke†
and Rolf Rossaint*
Background: Nitric oxide (NO) is a very reactive agent with potentially toxic
oxidation products such as nitrogen dioxide (NO2). Therefore, during NO
inhalation a constant inspired concentration and accurate measurement of NO
and NO2 concentrations are essential. The objective of this study was to test the
NO concentrations at various positions along the inspiratory limb of the
breathing circuit using a recently developed system to administer NO in phase
with inspiratory flow during mechanical ventilation (Servo 300 NO-A, Siemens,
Sweden). Furthermore, we tested whether an active heating system would
interfere with inspired NO concentrations.
Results: A sharp decline in the NO concentration was found between the
respirator’s inspiratory outlet and more distal points along the inspiratory limb of
the circuit. This finding was most evident when an active heating system was
mounted between those points.
Conclusions: The concentrations of NO and NO2 should be measured as near
to the patient as possible, as significant fluctuations of these concentrations
might be found along the inspiratory limb of the respiratory circuit especially
when an active heating system is used.
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Introduction
Inhalation of nitric oxide (NO) has been shown to selec-
tively dilate the pulmonary vascular bed in animals as well
as in humans [1–4]. Therefore, it has been used to reduce
pulmonary hypertension in neonates [5,6] or after cardiac
surgery [7,8]. In contrast to intravenously administered
vasodilators, inhaled NO does not exert any vasodilating
effect on the systemic circulation due to its rapid inactiva-
tion by haemoglobin when it enters the bloodstream
[9,10]. When given via inhalation in severe acute respira-
tory distress syndrome (ARDS), NO predominantly pro-
duces vasodilation in the ventilated areas of the lung.
Therefore, it does not only reduce pulmonary hyperten-
sion but it also redistributes blood flow towards the venti-
lated areas, thereby reducing intrapulmonary shunt and
improving arterial oxygenation [11].
For these reasons NO inhalation may become a wide-
spread adjunctive treatment for severe hypoxaemia or
pulmonary hypertension. However, the administration of
gaseous NO is complicated by the fact that NO reacts
with oxygen (O2) to form nitrogen dioxide (NO2) [9,10],
which is known to be a toxic agent causing pulmonary
epithelial damage [12,13]. Since the conversion of NO to
NO2 is dependent on the concentration of NO and O2 as
well as on their contact time, the concentrations of both
gases and their contact time should be generally mini-
mized to avoid potential toxic NO2 concentrations [14].
For the clinical use of inhaled NO it is therefore necessary
to monitor the inspiratory gas concentrations carefully.
Obviously, it is important to ensure a constant inspired
NO concentration. This might be problematic when NO
is administered continuously from a gas cylinder into the
inspiratory limb of the breathing system. Sydow et al [15]
reported significant fluctuations of NO concentrations
along the inspiratory limb of the respiratory tubing using a
simple system to administer NO continuously into the
circuit of a phasic flow ventilator [15]. These fluctuations
were dependent on the measurement site. To our know-
ledge, no data are available to show that fluctuations in the
NO concentrations occur along the inspiratory limb when
using a system to administer NO only during inspiration
and in proportion to flow.
Therefore, the aim of our study was to evaluate the NO and
NO2 concentrations along the inspiratory limb of the respi-
ratory tubing during mechanical ventilation and NO inhala-
tion. For that investigation we used a recently developed
NO delivery system which is integrated into a standard
respirator (Servo 300 NO-A, Siemens, Lund, Sweden) and
which has been shown to be accurate for the administration
of NO between 1 and 100 parts per million (ppm) [16].
Material and methods
Technique of NO administration
For the administration of NO during mechanical ventila-
tion we used a prototype of the Servo 300 NO-A. With this
device, NO is added into the part of the inspiratory circuit
which is inside the ventilator just before the inspiratory
outlet. An electronically controlled valve is used to add a
NO/nitrogen (N2) mixture proportional to flow into the
inspiratory gas stream. The NO/N2 mixture is delivered
from a cylinder. On the front panel of the ventilator the
inspired NO concentration can be adjusted between 0.3
and 25ppm. The scale is calibrated for a cylinder contain-
ing exactly 2500ppm NO in N2. For any different NO/N2
mixture the administered NO concentration would have
to be calculated accordingly.
NO and NO2 measurement
A chemiluminescence analyser (CLD 700, Eco Physics,
Duernten, Switzerland) was used for measuring NO and
NO2 concentrations. With this device, the response time
for NO measurements is dependent on the measurement
range. At 0.1ppm NO the response time is >30s and at
100ppm NO it is >6s. A 50-cm gas sampling line of this
machine was connected to measurement ports mounted at
four different positions along the inspiratory limb of the
respiratory system (Pos. 1–4). Pos. 1 was immediately
after the inspiratory outlet of the respirator; Pos. 2, 3 and 4
were each 25cm more distal along the inspiratory limb.
When an active humidification system was placed in the
inspiratory limb, it was mounted between Pos. 1 and
Pos. 2. For details of the measurement design see Figure 1.
Prior to the measurements the chemiluminescence ana-
lyzer was calibrated using defined calibration gases.
Study protocol
Using the pressure controlled mode of mechanical ventila-
tion, NO was administered in increasing doses of 0.1, 1, 10
and 100ppm into an FiO2 of 0.21, without any humidifier
mounted into the system. Each NO concentration was
administered for 10min before the first measurement was
taken. NO/NO2 was measured at each position (Pos. 1–4)
by chemiluminescence for at least 2min to obtain stable
values.
To investigate the effect of increasing O2 concentrations
the same set of measurements was then repeated for an
FiO2 of 0.5 and 1.0.
To investigate the effect of additional volume due to the
humidification system, the same set of measurements for
all NO concentrations and all FiO2 values was obtained
with an active humidification system (Concha Therm III
with Aerodyne humidification column, Kendall, Neustadt,
Germany) mounted into the respiratory tubing between
Pos. 1 and Pos. 2 (Fig 1). In order to discriminate between
the possible effect of the additional volume alone and a
possible reaction of NO with water in the humidification
system, all NO concentrations at all FiO2 values were
administered when the heating column of the humidifier
was empty and not active and repeated for a water-filled
heating column.
Data analysis
Data for NO and NO2 concentrations are given for each
individual set of measurements, in other words for each
NO dose, for each FiO2, for the setup without humidifica-
tion system (nohum), and for the setup including the inac-
tive humidification system (inacthum) as well as for the
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Figure 1
Schematic presentation of the experimental design used. At four
positions (Pos. 1 to Pos. 4) along the inspiratory limb of the respiratory
tubing, NO and NO2 concentrations were measured by means of
chemiluminescence (CLD 700 AL chemiluminometer). The upper part
of the figure demonstrates the measurement design without a
humidification system. In the lower part the site of the active
humidification system is indicated between Pos. 1 and Pos. 2.
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active humidification system (acthum) in place. NO mea-
surements are presented as percentages of the NO con-
centration set on the respirator. NO2 concentrations are
given as absolute values (ppm). To compare the NO con-
centrations at the different positions and for the different
setups, data for all FiO2 values and NO concentrations
from 1 to 100ppm were averaged and tested by means of
the paired students t-test. Data in figures are given as
mean±standard deviation.
Results
The individual measurements of NO concentrations at
the four different positions for the different FiO2 values
and for the different setups concerning the humidification
system are shown in Figure 2. We found a sharp decline
for all NO concentrations between Pos. 1 and Pos. 2 that
obviously was not influenced by the FiO2. For the setup
with an inactive or without humidification system, this
finding was strongly influenced by the high NO values at
Pos. 1 for 0.1ppm NO when expressed as a percentage of
the adjusted NO dose. Therefore, the values for 0.1ppm
NO were excluded from the statistical analysis of mean
values, which is shown in Figure 3. For all setups, a signif-
icantly lower NO concentration was found at Pos. 2–4
when compared to Pos. 1. The differences for the NO
values between Pos. 1 and 2 as well as between Pos. 1 and
4 are shown in Figure 4. Again, for this analysis all NO
measurements except for 0.1ppm NO were averaged for
the different FiO2 settings. The difference between Pos.
1 and 2 was significantly less pronounced when the inac-
tive or no humidification system were used.
The corresponding NO2 concentrations are shown in
Figure 5, again as individual measurements for all FiO2
values and for the different setups of the humidification
system.
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No humidification system Inactive humidification system Active humidification system
Individual NO measurements for the different NO concentrations set
(x-axis, NO) and the different FiO2 values as well as the different circuit
setups. The NO concentrations are expressed as a percentage of the
set NO concentration (y-axis). Each line of figures represents the
different settings for FiO2. Each column of figures represents the
different setups for the heating system.
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Figure 3
Nitric oxide (NO) concentrations as a percentage of the adjusted NO
dose (y-axis) for the different setups of the heating system (x-axis). The
different bars reflect the different measurement positions (see Fig 1).
Data are given as mean ± standard deviation. *P < 0.05, compared to
Pos. 1 for a given setup; §P < 0.05, compared to the active
humidification system (acthum) for a given position. inacthum, Inactive
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Figure 4
Differences in nitric oxide (NO) concentrations between different
positions as a percentage of the adjusted NO dose (y-axis) for the
different setups of the heating system (x-axis). The different bars reflect
the different measurement positions (see Fig 1). Data are given as
mean ± standard deviation. *P < 0.05, compared to the active
humidification system (acthum). inacthum, Inactive humidification












NO Pos 1-2 %























































































NO Pos 12 NO Pos 22


































Individual nitrix dioxide (NO2) measurements in parts per million (ppm,
y-axis) for the different nitric oxide (NO) concentrations adjusted (x-
axis, NO) and the different FiO2 values as well as the different circuit
setups. Each line of figures represents the different settings for FiO2.
Each column of figures represents the different setups for the heating
system.
Discussion
The most obvious conclusion from the data is that a signif-
icant variation of the NO concentrations can be found
along the inspiratory limb of the breathing system even
when a device to administer NO proportional to inspira-
tory flow, such as the Servo 300 NO-A, is used. The
highest NO concentrations were found immediately
behind the respirator outlet with a sharp decline to fairly
stable values in the more distal parts of the respiratory
tubing. Although this observation could be generally made
for all NO concentrations (0.1–100ppm) and for all differ-
ent heating system setups, the magnitude of this decrease
in NO along the inspiratory limb was dependent on the
presence of an active humidification system.
This pattern of inspiratory NO concentrations might be
explained in two different ways. The rather high NO con-
centrations adjacent to the inspiratory outlet might be
attributed to incomplete gas mixing inside the ventilator
which could result in potentially higher measured NO
values than those set. Alternatively, the sharp decline
between Pos. 1 and Pos. 2 might be explained by a rapid
reaction of NO in between both points of measurement so
that the actual amount of NO decreased. Our data suggest
that both possible mechanisms may play a role.
The observation that NO decreases significantly between
Pos. 1 and Pos. 2 even when no humidification system is
present between those points might suggest that incom-
plete gas mixing inside the small internal volume of the
respirator is responsible for that decline. Since no further
changes in NO concentration along the inspiratory limb of
the tubing could be observed distal to Pos. 2, it can be
concluded that the small distance between the respirators
outlet and the measurement at Pos. 2 is sufficient to
achieve a complete gas mixing. Fluctuations of NO con-
centrations have been shown for continuous flow delivery
of NO into the inspiratory circuit of a phasic-flow ventila-
tor [15]. These fluctuations could have been minimized
by using a mixing chamber. A study by Mourgeon et al
[17] showed that sequential NO delivery during con-
trolled ventilation with constant flow resulted in more
stable NO concentrations than continuous NO delivery.
However, when pressure support ventilation was used
even sequential NO delivery did not provide stable NO
concentrations [17]. In accordance with these findings, an
explanation for the fluctuations between Pos. 1 and Pos. 2
in our study might be that, during pressure-controlled
ventilation, a decelerating flow pattern results which
cannot be exactly followed by the mass flow controller of
the NO delivery device. As a result, a small asynchrony
between ventilator flow and NO flow would explain the
non-homogeneous gas mixing at Pos. 1.
However, the comparison between the different setups for
the heating system suggests that a form of reaction of NO
takes place between Pos. 1 and Pos. 2, resulting in a
decreased amount of NO at Pos. 2 in the presence of
water. As shown in Figure 3, the NO concentrations at the
positions distal to Pos. 1 were significantly higher for the
setups including no or an inactive humidification system,
when compared to the active water-filled heating column.
Since inclusion of the inactive heating column in between
Pos. 1 and Pos. 2 did not change NO at Pos. 2 compared to
the setup without the humidification system, it might be
concluded that the additional mixing volume of the
heating column as such does not play an important role for
the NO concentration. In contrast, for the water-filled
column, the difference between NO concentrations at
Pos. 1 and Pos. 2 is significantly higher (Fig 4), which
might indicate that NO reacts in the aqueous phase or at
the gaseous–aqueous interface of the humidification
system. Since NO is a very reactive chemical compound, a
variety of potential reactions could be responsible for the
observed decrease of NO in the active heating column
[9,10]. NO reacts with O2 in sequence with the end prod-
ucts HNO2 and HNO3 which dissolves into NO2– and
NO3– + H+. NO2 formation should be increased according
to the kinetics of this reaction with higher concentrations
of NO and O2 and a longer contact time between NO and
O2 [14] which results from the additional gas volume of
the heating column. This hypothesis is supported by the
NO2 measurements that show higher NO2 levels for a
given NO and FiO2 when the inactive humidification
system is compared to the setup without a heating
column. However, since this type of reaction alone does
not explain the differing findings for the active and the
inactive heating system, a second type of reaction might
take place preferentially at the gas–liquid interface or in
the aqueous phase of the water-filled column. This second
reaction type might be a further reaction of NO with NO2
which produces N2O3 dissolving again into HNO2 in the
presence of H2O [10]. With this second reaction, the
further consumption of NO in the water-filled heating
system could be explained as easily as the relatively lower
NO2 values at Pos. 2 for the active system when compared
to the inactive heating column (Fig 5) as NO2 will also be
decreased by this reaction. NO2 increases in the more
distal parts of the inspiratory tubing probably as a result of
the well known oxidation of NO to NO2. Studies measur-
ing further compounds of the above mentioned reactions
for different ventilator settings should clarify their impor-
tance for NO delivery.
In recent studies, the importance of measuring with fast
response time chemiluminescence machines has been
shown to assess the true breath-by-breath variability of
NO delivery systems [15,17,18]. In this study, we used a
chemiluminescence machine with a rather slow response
time. Therefore, we did not measure breath-by-breath
fluctuations of the inspired NO or even fluctuations
within one breath but instead mean NO and NO2
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concentrations for the different positions along the inspira-
tory tubing. This is clearly a drawback of the measure-
ment device we used as we cannot rule out that faster
fluctuations of NO might have occurred. However, there
was a clear pattern even for these slow NO fluctuations
depending on the presence of an active heating device.
In summary, we conclude that significant variations of NO
concentrations occur along the inspiratory limb of the res-
piratory tubing during inhalation of NO from 0.1 to
100ppm using the Servo 300 NO-A for NO delivery
during pressure-controlled ventilation. The major part of
these fluctuations occurs in the first 30cm of the tubing
after the inspiratory outlet of the respirator. These fluctua-
tions are due to incomplete gas mixing in the small inter-
nal volume of the respirator. Furthermore, the chemical
reaction and dissolving of NO in the aqueous phase of an
active heating system may play a major role in the sharp
decrease in NO concentrations across the humidification
and heating system. Since these data have been obtained
in a laboratory study, further clinical studies are needed to
clarify whether this phenomenon is clinically important.
However, the presented data emphasize that the NO and
NO2 concentrations should be measured as distally as pos-
sible in the inspiratory limb of the system to get the best
estimate of the real inhaled concentration. Furthermore,
one should be aware that the inclusion of an active heating
and humidification system into the respiratory tubing
alters the administered NO concentrations. Finally, it
could be speculated that, along the humid atmosphere of
the more distal parts of the respiratory system of the
patient, further NO is consumed by chemical reaction
leading to a decrease in the efficient NO concentration at
the site of action which is the alveolo–capillary interface.
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